The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2020

Filed:

Jul. 26, 2018
Applicant:

Amicus Therapeutics, Inc., Cranbury, NJ (US);

Inventors:

Elfrida Benjamin, Millstone Township, NJ (US);

Hung V. Do, New Hope, PA (US);

Xiaoyang Wu, Edison, NJ (US);

John Flanagan, East Windsor, NJ (US);

Brandon Alan Wustman, San Diego, CA (US);

Assignee:

Amicus Therapeutics, Inc., Cranbury, NJ (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01); A61K 31/445 (2006.01); G01N 33/68 (2006.01); C12Q 1/34 (2006.01);
U.S. Cl.
CPC ...
A61K 31/445 (2013.01); C07K 14/00 (2013.01); C12Q 1/34 (2013.01); G01N 33/6893 (2013.01); G01N 2333/47 (2013.01); G01N 2333/94 (2013.01); G01N 2800/38 (2013.01); G01N 2800/52 (2013.01);
Abstract

The present invention provides methods to determine whether a patient with a lysosomal storage disorder will benefit from treatment with a specific pharmacological chaperone. The present invention exemplifies an in vitro method for determining α-galactosidase A responsiveness to a pharmacological chaperone such as 1-deoxygalactonojirimycin in a cell line expressing a mutant from of α-galactosidase A. The invention also provides a method for diagnosing Fabry disease in patients suspected of having Fabry disease.


Find Patent Forward Citations

Loading…